Literature DB >> 31606605

New Fissure-Attached Nodules in Lung Cancer Screening: A Brief Report From The NELSON Study.

Daiwei Han1, Marjolein A Heuvelmans2, Carlijn M van der Aalst3, Lisa H van Smoorenburg4, Monique D Dorrius1, Mieneke Rook5, Kristiaan Nackaerts6, Joan E Walter7, Harry J M Groen8, Rozemarijn Vliegenthart1, Harry J de Koning3, Matthijs Oudkerk9.   

Abstract

INTRODUCTION: In incidence lung cancer screening rounds, new pulmonary nodules are regular findings. They have a higher lung cancer probability than baseline nodules. Previous studies have shown that baseline perifissural nodules (PFNs) represent benign lesions. Whether this is also the case for incident PFNs is unknown. This study evaluated newly detected nodules in the Dutch-Belgian randomized-controlled NELSON study with respect to incidence of fissure-attached nodules, their classification, and lung cancer probability.
METHODS: Within the NELSON trial, 7557 participants underwent baseline screening between April 2004 and December 2006. Participants with new nodules detected after baseline were included. Nodules were classified based on location and attachment. Fissure-attached nodules were re-evaluated to be classified as typical, atypical, or non-PFN by two radiologists without knowledge of participant lung cancer status.
RESULTS: One thousand four hundred eighty-four new nodules were detected in 949 participants (77.4% male, median age 59 years [interquartile range: 55-63 years]) in the second, third, and final NELSON screening round. Based on 2-year follow-up or pathology, 1393 nodules (93.8%) were benign. In total, 97 (6.5%) were fissure-attached, including 10 malignant nodules. None of the new fissure-attached malignant nodules was classified as typical or atypical PFN.
CONCLUSIONS: In the NELSON study, 6.5% of incident lung nodules were fissure-attached. None of the lung cancers that originated from a new fissure-attached nodule in the incidence lung cancer screening rounds was classified as a typical or atypical PFN. Our results suggest that also in the case of a new PFN, it is highly unlikely that these PFNs will be diagnosed as lung cancer.
Copyright © 2019 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lung cancer; Pulmonary nodule; Screening

Mesh:

Year:  2019        PMID: 31606605     DOI: 10.1016/j.jtho.2019.09.193

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  3 in total

1.  Strategies for Reducing False-Positive Screening Results for Intermediate-Size Nodules Evaluated Using Lung-RADS: A Secondary Analysis of National Lung Screening Trial Data.

Authors:  Mark M Hammer; Andetta R Hunsaker
Journal:  AJR Am J Roentgenol       Date:  2022-03-23       Impact factor: 6.582

2.  Evaluation of a novel deep learning-based classifier for perifissural nodules.

Authors:  Daiwei Han; Marjolein Heuvelmans; Mieneke Rook; Monique Dorrius; Luutsen van Houten; Noah Waterfield Price; Lyndsey C Pickup; Petr Novotny; Matthijs Oudkerk; Jerome Declerck; Fergus Gleeson; Peter van Ooijen; Rozemarijn Vliegenthart
Journal:  Eur Radiol       Date:  2020-12-02       Impact factor: 5.315

3.  Perifissural nodules: ready for application into lung cancer CT screening?

Authors:  Anton Schreuder; Cornelia M Schaefer-Prokop
Journal:  Ann Transl Med       Date:  2020-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.